These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 11519979

  • 21. Use of danaparoid sodium (Orgaran) as an alternative to heparin sodium during cardiopulmonary bypass: a clinical evaluation of six cases.
    Fernandes P, Mayer R, MacDonald JL, Cleland AG, Hay-McKay C.
    Perfusion; 2000 Nov; 15(6):531-9. PubMed ID: 11131218
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s.
    Lubenow N, Warkentin TE, Greinacher A, Wessel A, Sloane DA, Krahn EL, Magnani HN.
    Thromb Res; 2006 Nov; 117(5):507-15. PubMed ID: 15907979
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Heparin-induced thrombocytopenia (HIT): in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin).
    Baumgärtel MW, Eichler P, Glöckner WM, Ranze O, Greinacher A.
    Eur J Haematol; 2000 Aug; 65(2):148-9. PubMed ID: 10966178
    [No Abstract] [Full Text] [Related]

  • 26. [Heparin-induced thrombocytopenia].
    Depasse F, Samama MM.
    Ann Biol Clin (Paris); 2000 Aug; 58(3):317-26. PubMed ID: 10846236
    [Abstract] [Full Text] [Related]

  • 27. Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure.
    Westphal K, Martens S, Strouhal U, Matheis G, Lindhoff-Last E, Wimmer-Greinecker G, Lischke V.
    Thorac Cardiovasc Surg; 1997 Dec; 45(6):318-20. PubMed ID: 9477469
    [Abstract] [Full Text] [Related]

  • 28. Clinical presentation, temporal relationship, and outcome in thirty-three patients with type 2 heparin-induced thrombocytopenia after cardiotomy.
    Wan C, Warner M, De Varennes B, Ergina P, Cecere R, Lachapelle K.
    Ann Thorac Surg; 2006 Jul; 82(1):21-6. PubMed ID: 16798180
    [Abstract] [Full Text] [Related]

  • 29. Successful use of danaparoid in treatment of heparin-induced thrombocytopenia during twin pregnancy.
    Gill J, Kovacs MJ.
    Obstet Gynecol; 1997 Oct; 90(4 Pt 2):648-50. PubMed ID: 11770579
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Danaparoid use for haemodialysis in a morbidly obese patient with heparin-induced thrombocytopenia - Need for a higher than recommended weight-based dosing.
    Castelino RL, Maddula M, Tarafdar S, Sud K, Kairaitis L.
    Thromb Res; 2019 Aug; 180():70-73. PubMed ID: 31229923
    [Abstract] [Full Text] [Related]

  • 32. Heparin-induced thrombocytopenia: what clinicians need to know.
    Chong BH, Isaacs A.
    Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Heparin-induced thrombocytopenia type II: successful use of Orgaran (ORG 10172) in intensive care patients.
    Burkhard-Meier U, Söhngen D, Schultheiss HP, Greinacher A, Schwartzkopff B, Vogt M, Heyll A, Schneider W.
    Intensive Care Med; 1995 Jun; 21(6):542-3. PubMed ID: 7560499
    [No Abstract] [Full Text] [Related]

  • 35. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
    Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
    [No Abstract] [Full Text] [Related]

  • 36. Heparin-induced thrombocytopenia.
    Prescrire Int; 2013 May; 22(138):124-5. PubMed ID: 23819174
    [Abstract] [Full Text] [Related]

  • 37. The use of danaparoid to manage coagulopathy in a neurosurgical patient with heparin-induced thrombocytopenia type II and intracerebral haemorrhage.
    Hertle DN, Hähnel S, Richter GM, Unterberg A, Sakowitz OW, Kiening KL.
    Br J Neurosurg; 2011 Feb; 25(1):117-9. PubMed ID: 20707682
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II.
    Christiansen S, Jahn UR, Meyer J, Scheld HH, Van Aken H, Kehrel BE, Hammel D.
    Ann Thorac Surg; 2000 Mar; 69(3):774-7. PubMed ID: 10750760
    [Abstract] [Full Text] [Related]

  • 40. [Thrombosis of a cardiopulmonary bypass circuit despite recommended hypocoagulation with danaparoid during the acute phase of type II heparin-induced thrombocytopenia].
    Salmi L, Elalamy I, Leroy-Matheron C, Houel R, Thébert D, Duvaldestin P.
    Ann Fr Anesth Reanim; 2006 Mar; 25(11-12):1144-8. PubMed ID: 17174213
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.